Evaluation of 68 Ga-PSMA-11 PET/CT: a Phase 1 clinical study in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer.

Anri InakiAtsushi MizokamiHiroshi WakabayashiKouji IzumiYoshifumi KadonoTadashi ToyamaShizuko TakaharaToshinori MurayamaSeigo Kinuya

Published in: Annals of nuclear medicine (2024)

Ga-PSMA-11 has a favourable safety and tolerability profile in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer, which is comparable to previous observations in other populations.

Keyphrases

pet ct
prostate cancer
positron emission tomography
radical prostatectomy
pulmonary embolism
randomized controlled trial
open label
computed tomography
double blind
pet imaging
placebo controlled